ScholarIQanswers from OpenAlex
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
PaperCitations, authors & open-access status
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 have?
ScholarIQcitation count
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 has 507 citations in the OpenAlex counts ScholarIQ stores.
When was Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 published?
ScholarIQyear
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 has 2021 year in the ScholarIQ index.
What is the open-access status of Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1?
ScholarIQoa status
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 has bronze oa status in the ScholarIQ index.
What is the DOI of Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1?
ScholarIQdoi
The DOI for Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 is on the source record.
What is the PMID of Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1?
ScholarIQpmid
The PMID for Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 is on the source record.
What is the OpenAlex record for Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1?
ScholarIQopenalex
The OpenAlex for Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 is on the source record.